Company Filing History:
Years Active: 2010-2020
Title: The Innovative Contributions of Hong Li
Introduction
Hong Li is a prominent inventor based in Edison, NJ (US), known for his significant contributions to the field of pharmaceuticals. With a total of 12 patents to his name, he has made remarkable strides in developing compounds that address critical health issues.
Latest Patents
Among his latest patents is the invention of Substituted Quinolizine Derivatives, which are useful as HIV integrase inhibitors. This invention relates to compositions comprising at least one Substituted Quinolizine Derivative and methods for using these derivatives to treat or prevent HIV infection in a subject. Another notable patent involves Factor IXa inhibitors, which provide compounds and pharmaceutical compositions aimed at treating various cardiovascular conditions, including unstable angina and myocardial infarction.
Career Highlights
Throughout his career, Hong Li has worked with esteemed companies such as Merck Sharp & Dohme Corp. and Merck & Co., Inc. His work in these organizations has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.
Collaborations
Hong Li has collaborated with talented individuals in his field, including Cameron James Smith and Yi-Heng Chen. These partnerships have fostered innovation and have been instrumental in advancing their shared goals in pharmaceutical research.
Conclusion
In summary, Hong Li's innovative work and numerous patents reflect his dedication to improving health outcomes through scientific advancements. His contributions continue to influence the pharmaceutical landscape significantly.